Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Non-Randomized, Open-label Phase II Trial Testing the Activity of XL092 (Zanzalintinib) in Patients With Advanced Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
This phase II trial tests how well zanzalintinib (XL092) works in treating patients with leiomyosarcoma that has spread from where it first started to other pl…
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaBone Sarcoma+7 more
Estimated
~$10 – $6,250
Northwestern UniversityNCT06571734
Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone
This study compares carbon ion therapy, surgery, and proton therapy to determine if one has better disease control and fewer side effects. There are three type…
Bone SarcomaChondrosarcomaChordoma+2 more
Estimated
~$10 – $750
Mayo ClinicNCT05033288